// App-Quantinova.ai

e22049 : The impact of prothrombotic mutations, PSGL-1 VNTR polymorphism, tissue factor, and soluble P-selectin on venous thromboembolism in cancer patients with adenocarcinoma.

Researchers

Presenter

  • Mustafa Bozkurt

Principal Investigators

  • Kerem Okutur

  • Kezban Nur Planci

  • Veysel Sabri Hancer

  • Coskun Tecimer

  • Reyhan Diz Kucukkaya

  • Gokhan Demir

  • Kubra Aydin

  • Esat NamAlAkin Ozturk

Medical Centers

  • Istanbul Bilim University of Medicine, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey

  • Istanbul Bilim University Faculty of Medicine, Department of Medical Biology and Genetics, Istanbul, TurkeyHaseki Research and Educational Hospital, Department of Internal Medicine, Division of Medical Oncology, Istanbul, TurkeyIstanbul Bilim University Faculty of Medicine, Department of Internal Medicinei Division of Medical Oncology, Istanbul, Turkey

  • Ankara Dr. Abdurrahman Yurtaslan Oncology Education and Research Hospital, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Turkey

  • Bagcilar Education and Research Hospital,Department of Internal Medicine, Division of Medical Oncology, Istanbul, Turkey

  • Metropolitan Florence Nightingale Hospital, Istanbul, Turkey

  • Sureyyapasa Thoracic Diseases and Thoracic Surgery Training and Research Hospital, Department of Medical Oncology, Istanbul, Turkey

  • Acibadem University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved